علاج اعتلال حجاج العين الخفيف في مرض غريفز مع جحوظ العين وتراجع الجفن البسيط

References

DOI: 10.1530/EJE-21-0479

• Patients whose features of GO have only a minor impact on daily life that have insufficient impact to justify immunomodulation or surgical treatment.
• Minor lid retraction (<2 mm)
• Mild soft-tissue involvement
• Exophthalmos <3 mm above normal for race and gender
• No or intermittent diplopia and corneal exposure responsive to lubricants
• Mild GO should be treated with local treatments and general measures to control risk factors; a 6-month selenium supplementation should be given to patients with mild and active GO of recent onset, because it improves eye manifestations and QoL and usually prevents GO progression to more severe forms.
• All patients with GO should be extensively treated locally with artificial tears at all times in the course of their disease unless corneal exposure requires higher protection than ophthalmic gels or ointment, especially at nighttime.
• Therefore, a watchful strategy and local treatments are sufficient.